Log in to save to my catalogue

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outc...

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1826737633

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations

About this item

Full title

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations

Publisher

England: BMJ Publishing Group LTD

Journal title

Journal of medical genetics, 2016-11, Vol.53 (11), p.729-734

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

BackgroundThe RET proto-oncogene is responsible for the pathogenesis of hereditary (98%) and sporadic (40%) medullary thyroid carcinoma (MTC). In sporadic MTC, somatic RET mutations are associated with a poor prognosis.ObjectivesWe looked at the genetic profile of patients with advanced and metastatic MTC. The correlation between these mutations an...

Alternative Titles

Full title

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1826737633

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1826737633

Other Identifiers

ISSN

0022-2593

E-ISSN

1468-6244

DOI

10.1136/jmedgenet-2016-103833

How to access this item